✦ LIBER ✦

Neuroendocrine and behavioral responses to mCPP in Obsessive–Compulsive Disorder

✍ Scribed by Sumant Khanna; John P John; P Lakshmi Reddy

Book ID: 114236509
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 139 KB
Volume: 26
Category: Article
ISSN: 0306-4530
DOI: 10.1016/s0306-4530(00)00048-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroendocrine responses to intravenous

Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder

✍ N.A. Fineberg; P.J. Cowen; J.W. Kirk; S.A. Montgomery 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Repeat M-CPP challenge during fluoxetine

Repeat M-CPP challenge during fluoxetine treatment in obsessive-compulsive disorder: Behavioral and neuroendocrine responses

✍ Eric Hollander; Concetta DeCaria; Michael Fay; Michael R. Liebowitz 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 89 KB

P-16-9 - Neuroendocrine responses to ips

P-16-9 - Neuroendocrine responses to ipsapirone in patients with panic and obsessive compulsive disorder

✍ T.R. Norman; M. Apostolopoulos; E. Barson; G.D. Burrows; A. Cockram; F.K. Judd 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Challenge studies in obsessive compulsiv

Challenge studies in obsessive compulsive disorder: Recent developments with MCPP and pentagastrin

✍ H.G.M. Westenberg; K.L. Ho Pian; A.S. de Leeuw; J.A. den Boer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 123 KB

Amygdala responses to human faces in obs

Amygdala responses to human faces in obsessive-compulsive disorder

✍ Paul A. Cannistraro; Christopher I. Wright; Michelle M. Wedig; Brian Martis; Lis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Neuroendocrine predictors of response to

Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive–compulsive disorder

✍ Sanjay J. Mathew; Jeremy D. Coplan; Kathryn A. Perko; Raymond R. Goetz; Manuel d 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

## The current study examines the neuroendocrine response to intravenous clomipramine (IV CMI) in oral CMI-resistant obsessive-compulsive disorder (OCD) patients on day 1 and day 14 of treatment to identify predictors of response. Forty-four OCD patients with an inadequate response or poorly toleran